Junya Furukawa, Ryotaro Tomida, Kei Daizumoto, Yutaro Sasaki, Tomoya Fukawa. Advances in Adjuvant Therapy for Renal Cell Carcinoma: Perspectives on Risk Stratification and Treatment Outcomes. International journal of urology : official journal of the Japanese Urological Association. 2025
Nobutaka Nishimura, Makito Miyake, Kota Iida, Tatsuki Miyamoto, Ryotaro Tomida, Kazuyuki Numakura, Junichi Inokuchi, Takahiro Yoneyama, Eijiro Okajima, Shugo Yajima, et al. Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis. World Journal of Urology. 2024. 42. 1
Yutaro Sasaki, Yasuyo Yamamoto, Kyotaro Fukuta, Kazuyoshi Izumi, Fumiya Kadoriku, Kei Daizumoto, Keito Shiozaki, Ryotaro Tomida, Yoshito Kusuhara, Tomoya Fukawa, et al. Cutaneous ureterostomy following robot-assisted radical cystectomy: a multicenter comparative study of transperitoneal versus retroperitoneal techniques. World journal of urology. 2024. 42. 1. 591-591
Yutaro Sasaki, Narushi Yokota, Shuhei Nozaki, Satoshi Harada, Tetsuhiro Yano, Mitsuki Nishiyama, Saki Kobayashi, Ryoei Minato, Kei Daizumoto, Ryotaro Tomida, et al. Robot-assisted nephroureterectomy using the GelPoint Platform with a focus on optimizing the port position and specimen retrieval. Asian journal of endoscopic surgery. 2024. 17. 4. e13386
Yutaro Sasaki, Kyotaro Fukuta, Fumiya Kadoriku, Kei Daizumoto, Keito Shiozaki, Ryotaro Tomida, Yoshito Kusuhara, Tomoya Fukawa, Yutaka Yanagihara, Ryoichi Nakanishi, et al. Retroperitoneal cutaneous ureterostomy following radical cystectomy: A multicenter comparative study of robotic versus open surgery. International journal of urology : official journal of the Japanese Urological Association. 2024
2025/05 - Springer Nature Springer Nature Author Service Award
2025/05 - Springer Nature Springer Nature Editorial Contribution Award
2024/07 - TEKKフォーラム 2024 TEKKフォーラム研究奨励賞 Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data
2024/04 - 日本泌尿器科学会 第111回日本泌尿器科学会総会Best Poster Award Cabozantinib or axitinib for second-line treatment after nivolumab plus ipilimumab? ~from JUOG multicenter retrospective real-world data~
2023/10 - 日本癌治療学会 第23回一般社団法人日本癌治療学会研究奨励賞 Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data
2022/07 - TEKKフォーラム研究奨励賞 TEKKフォーラム2022
2020/03 - 四国がんセンター年間優秀論文賞 Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data
